Literature DB >> 8472660

Three-dimensional brain metabolic imaging in patients with toxic encephalopathy.

T J Callender1, L Morrow, K Subramanian, D Duhon, M Ristovv.   

Abstract

Thirty-three workers, ages 24 to 63, developed clinical toxic encephalopathy after exposure to neurotoxins and were studied by SPECT brain scans. Five were exposed to pesticides, 13 were acutely exposed to mixtures of solvents, 8 were chronically exposed to mixtures of hazardous wastes that contained organic solvents, 2 were acutely exposed to phosgene and other toxins, and 5 had exposures to hydrogen sulfide. Twenty-nine had neuropsychological testing and all had a medical history and physical. Of the workers who had a clinical diagnosis of toxic encephalopathy, 31 (93.9%) had abnormal SPECT brain scans with the most frequent areas of abnormality being temporal lobes (67.7%), frontal lobes (61.3%), basal ganglia (45.2%), thalamus (29.0%), parietal lobes (12.9%), motorstrip (9.68%), cerebral hemisphere (6.45%), occipital lobes (3.23%), and caudate nucleus (3.23%). Twenty-three out of 29 (79.3%) neuropsychological evaluations were abnormal. Other modalities when performed included the following percentages of abnormals: NCV, 33.3%; CPT sensory nerve testing, 91.3%; vestibular function testing, 71.4%; olfactory testing, 89.2%; sleep EEG analysis, 85.7%; EEG, 8.33%; CT, 7.14%; and MRI brain scans, 28.6%. The complex of symptoms seen in toxic encephalopathy implies dysfunction involving several CNS regions. This series of patients adds to the previous experience of brain metabolic imaging and demonstrates that certain areas of the brain are typically affected despite differences in toxin structure, that these lesions can be globally defined by SPECT/PET brain scans, that these lesion correlate well with clinical and neuropsychological testing, and that such testing is a useful adjunct to previous methods. EEG and structural brain imaging such as CT and MRI are observed to have poor sensitivity in this type of patient. Additional metabolic imaging studies need to be done to explore dose, time, and specific toxin effects as well as mechanisms of toxicity and olfactory migration.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8472660     DOI: 10.1006/enrs.1993.1039

Source DB:  PubMed          Journal:  Environ Res        ISSN: 0013-9351            Impact factor:   6.498


  10 in total

1.  Focal hepatic encephalopathy with status epilepticus: incomplete recovery after hepatic transplantation.

Authors:  J M Annoni; E Giostra; M Goumaz; D Slosman; A Hadengue; G Mentha
Journal:  Dig Dis Sci       Date:  1997-04       Impact factor: 3.199

2.  Multiple chemical sensitivity and idiopathic environmental intolerance (part two).

Authors:  Mitsuyasu Watanabe; Hideki Tonori; Yoshiharu Aizawa
Journal:  Environ Health Prev Med       Date:  2003-01       Impact factor: 3.674

3.  Activation of purinergic receptor subtypes modulates odor sensitivity.

Authors:  Colleen C Hegg; Denise Greenwood; Wei Huang; Pengcheng Han; Mary T Lucero
Journal:  J Neurosci       Date:  2003-09-10       Impact factor: 6.167

4.  Magnetic resonance imaging in occupational chronic solvent encephalopathy.

Authors:  Petra Keski-Säntti; Riitta Mäntylä; Antti Lamminen; Hanna-Kaisa Hyvärinen; Markku Sainio
Journal:  Int Arch Occup Environ Health       Date:  2008-10-21       Impact factor: 3.015

5.  Occupational solvent exposure and brain function: an fMRI study.

Authors:  Cheuk Ying Tang; David M Carpenter; Emily L Eaves; Johnny Ng; Nimalya Ganeshalingam; Clifford Weisel; Hua Qian; Gudrun Lange; Nancy L Fiedler
Journal:  Environ Health Perspect       Date:  2011-02-04       Impact factor: 9.031

6.  Profile of patients with chemical injury and sensitivity.

Authors:  G Ziem; J McTamney
Journal:  Environ Health Perspect       Date:  1997-03       Impact factor: 9.031

7.  Clinical characteristics of chemical sensitivity: an illustrative case history of asthma and MCS.

Authors:  G H Ross
Journal:  Environ Health Perspect       Date:  1997-03       Impact factor: 9.031

8.  Corrosion of Polished Cobalt-Chrome Stems Presenting as Cobalt Encephalopathy.

Authors:  Stephen S Tower; Dana J Medlin; Robert L Bridges; Christina S Cho
Journal:  Arthroplast Today       Date:  2020-12-02

Review 9.  The Legacy of the TTASAAN Report-Premature Conclusions and Forgotten Promises: A Review of Policy and Practice Part I.

Authors:  Dan G Pavel; Theodore A Henderson; Simon DeBruin
Journal:  Front Neurol       Date:  2022-03-28       Impact factor: 4.086

10.  F-18 FDG PET brain imaging in symptomatic arthroprosthetic cobaltism.

Authors:  Robert L Bridges; Christina S Cho; Marc R Beck; Bradford D Gessner; Stephen S Tower
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-12-20       Impact factor: 9.236

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.